Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi (IST:GENIL)
Turkey flag Turkey · Delayed Price · Currency is TRY
148.90
+0.30 (0.20%)
Feb 28, 2025, 10:00 AM GMT+3

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Company Description

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide.

The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric.

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV for the development of molecule SUL-238 as a treatment for Alzheimer's disease and other neurodegenerative diseases.

The company was incorporated in 1997 and is headquartered in Çankaya, Turkey.

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi
Country Turkey
Founded 1997
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 622
CEO Abidin Gulmus

Contact Details

Address:
Mustafa Kemal District 2119
Çankaya, 06520
Turkey
Phone 90 312 219 62 19
Website genilac.com.tr

Stock Details

Ticker Symbol GENIL
Exchange Istanbul Stock Exchange
Fiscal Year January - December
Reporting Currency TRY
ISIN Number TREGENL00024
SIC Code 2834

Key Executives

Name Position
Abidin Gulmus Chairman of the Board and GM
Semra Gulmus Founder
Dr. Deniz Karagulle Vice President of Sales and Marketing
Yagmur Selin Gulmus Kolay Assistant General Manager of Strategy and Corporate Development